Appendicectomy combined with standard medical therapy is superior to standard medical therapy alone in maintaining remission ...

Appendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

With over 250 peer-reviewed publications, he has made significant contributions to medical literature, shedding light on the treatment and understanding of ulcerative colitis and Crohn's disease.

The study findings suggest "that JAK ... which compared endoscopic remission rates and adverse events for ulcerative colitis patients treated with JAK inhibitors or ustekinumab after failure ...

“These impressive findings show the potential of icotrokinra to transform the treatment paradigm for people living with ...

The findings not only deepen our understanding of UC pathogenesis but also open doors to novel treatments targeting EBV-driven inflammation. Ulcerative colitis (UC) is a chronic, relapsing disease ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

A third of patients with active ulcerative colitis (UC) experienced clinical ... “Most patients showed significant symptom and endoscopic score improvements after just eight weeks of treatment.

PSC is closely linked with autoimmune colitis like ulcerative colitis or Crohn’s colitis ... Antibiotics are required often if there is fever and patients may need endoscopic retrograde ...